Imagine if losing weight were as simple as swallowing a daily pill-no needles, no injections and no anxiety. If you're among ...

Eli Lilly announced trial results for its weight-loss medication, orforglipron, in August. Orforglipron is a once-daily oral ...

An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease's progression compared to a placebo.

In two studies, semaglutide failed to slow decline in thousands of people with early stages of Alzheimer's disease.

While the WHO study saw reports of suicidal thoughts were slightly higher for semaglutide in particular, the warning applies ...

A first-of-its-kind oral drug boosts muscle metabolism to improve blood sugar and body composition is now headed into larger clinical trials. Lowering blood sugar and increasing fat burning – without ...

Oral semaglutide—a key ingredient in obesity and diabetes drugs Ozempic and Wegovy—didn’t slow Alzheimer’s disease in two ...

The new drug will target weight loss for people with obesity and type 2 diabetes.

GLP-1 medications have been a life-changing tool to help people manage their blood sugar and lose weight. But the most popular forms of these medications have a big drawback: You have to inject ...

Novo Nordisk A/S left open the door for additional work on its pill version of Ozempic for Alzheimer’s disease after a pair ...

FDA is reviewing a new diabetes pill and oral Ozempic alternatives, raising questions about safety, access, pricing ...

Next-generation pills and monthly injectables promise more choice, fewer side effects and broader health benefits.